1. 176Antibiotic Prescribing Adherence to Procalcitonin (PCT)-Generated Recommendations in Two Academic Medical Intensive Care Units (MICUs). (December 2014) Authors: Schwartz, David N.; Cooke, Jon; Peglow, Sarah Rebecca; Lyles, Rosie; Gueret, Renaud; Xamplas, Renee; Singh, Kamaljit; Niklinski, Waldemar; Cypser, Ryan; Fogg, Louis; Weinstein, Robert A; Balk, Robert Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial. Issue 7 (July 2015) Authors: Moss, Richard B; Flume, Patrick A; Elborn, J Stuart; Cooke, Jon; Rowe, Steven M; McColley, Susanna A; Rubenstein, Ronald C; Higgins, Mark; VX11-770-110 (KONDUCT) Study Group Journal: Lancet Issue: Volume 3:Issue 7(2015) Page Start: 524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study. Issue 2 (February 2016) Authors: Davies, Jane C; Cunningham, Steve; Harris, William T; Lapey, Allen; Regelmann, Warren E; Sawicki, Gregory S; Southern, Kevin W; Robertson, Sarah; Green, Yulia; Cooke, Jon; Rosenfeld, Margaret Journal: Lancet Issue: Volume 4:Issue 2(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗